U.S. FDA Head Says First Of 60 Foreign Offices To Open In China This Year
This article was originally published in PharmAsia News
Executive Summary
U.S. FDA plans to kick off a vast expansion of the agency's presence in other countries by opening its first office in China before the end of the year. Commissioner Andrew von Eschenbach said the first office in China will be among 60 the agency plans to establish abroad within the next year. India is getting a particular focus by the FDA, which also plans to focus on Latin America and the Middle East. He said in an interview the agency is trying to send a clear signal drug makers and other companies it oversees will not get access to the U.S. market unless their products comply with U.S. quality standards. (Click here for more - a subscription may be required